/
•
•
Detailed stories on technology startups, business and economic current affairs.
The hospital chain’s regional as well as insured patient focus has stood it in good stead so far. Its plans to expand could pose challenges though.

Sitting in their first-floor office in Thane, a Mumbai suburb, the father-son duo of Ajay and Ankit Thakker exude a quiet confidence. The promoters of the NSE-listed Jupiter Life Line Hospitals have good reason.
Though a small hospital chain, with less than 1,000 operational beds and largely concentrated in Maharashtra, Jupiter Life Line delivers an operating margin that matches the biggest in the business. It recorded a 23.4% EBITDA margin for the first nine months of 2024-25—compared to 14% for Apollo Hospital Enterprises and 20% for Fortis Healthcare. Institutional investors have taken a note. The FII holding in the stock …
IRDAI wants to fix a model where distributors chasing high commissions push unsuitable policies, hurting customers. The regulator should brace for a major industry pushback.
Its lending business is doing the heavy lifting while payments and asset management lag, raising questions over its full-stack narrative.
A public listing will help clean up the hospital chain’s balance sheet after the costly Sahyadri acquisition. But depressed metrics, integration risks and lofty valuations make this far from a clean turnaround story.